J&J unit and Gilead's combo HIV pill Complera gets FDA OK

08/10/2011 | Forbes

The FDA approved Complera, an oral HIV drug containing Truvada, from Gilead Sciences, and Edurant, from Johnson & Johnson unit Tibotec. Complera is indicated for once-daily use by previously untreated patients.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA